
Results
34
These companies have grown profits at a double digit rate for 5 years or more. And they have net cash.
34 companies
Shanghai Allist Pharmaceuticals
Market Cap: CN¥47.5b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China.
688578
CN¥101.88
7D
-10.8%
1Y
89.3%
Imeik Technology DevelopmentLtd
Market Cap: CN¥47.4b
Engages in the research and development, production, and transformation of biomedical soft tissue repair materials in China.
300896
CN¥151.92
7D
-7.1%
1Y
-31.6%
Chengdu Kanghong Pharmaceutical Group
Market Cap: CN¥30.5b
Research, develops, manufactures, and distributes medicine for ophthalmic, neuropsychiatric and other applications in China.
002773
CN¥30.87
7D
-4.8%
1Y
59.7%
Hanmi Pharm
Market Cap: ₩5.4t
A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.
A128940
₩449,000.00
7D
10.7%
1Y
33.4%
Jamjoom Pharmaceuticals Factory
Market Cap: ر.س10.9b
Engages in the manufacture and distribution of pharmaceutical and consumer products in the Kingdom of Saudi Arabia, Gulf, Iraq, Egypt, North Africa, and internationally.
4015
ر.س155.00
7D
1.1%
1Y
-5.1%
BioArctic
Market Cap: SEK 25.0b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOA B
SEK 282.20
7D
-4.1%
1Y
96.7%
Anhui Anke Biotechnology (Group)
Market Cap: CN¥18.2b
Anhui Anke Biotechnology (Group) Co., Ltd.
300009
CN¥10.84
7D
6.0%
1Y
15.9%
Aurinia Pharmaceuticals
Market Cap: US$1.7b
A biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs.
AUPH
US$13.17
7D
7.2%
1Y
82.7%
Neuren Pharmaceuticals
Market Cap: AU$2.6b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$20.69
7D
-3.3%
1Y
68.6%
Changzhou Qianhong BiopharmaLTD
Market Cap: CN¥11.6b
Manufactures and distributes polysaccharide and protease drugs in China.
002550
CN¥9.02
7D
1.2%
1Y
41.4%
Soho Global Health
Market Cap: Rp25.9t
Together with its subsidiaires, operates as a healthcare company in Indonesia.
SOHO
Rp2,040.00
7D
0%
1Y
195.7%
Bonesupport Holding
Market Cap: SEK 13.9b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 211.20
7D
-9.0%
1Y
-35.9%
Indegene
Market Cap: ₹128.7b
Operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally.
INDGN
₹539.05
7D
-1.6%
1Y
-18.7%
BioGaia
Market Cap: SEK 10.2b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 100.60
7D
-3.1%
1Y
-7.2%
Zhejiang Yatai Pharmaceutical
Market Cap: CN¥6.5b
Researches, produces, sells, and exports pharmaceutical products in China and internationally.
002370
CN¥9.06
7D
27.2%
1Y
174.5%
Sunmax Biotechnology
Market Cap: NT$21.5b
A biomedical company, develops, manufactures, and markets collagen-based medical devices in Taiwan and Mainland China.
4728
NT$393.00
7D
-1.3%
1Y
41.9%
Tibet Weixinkang Medicine
Market Cap: CN¥4.9b
Engages in the research and development, production, and sale of chemical drugs and their bulk drugs in China.
603676
CN¥11.12
7D
-6.1%
1Y
9.4%
Zentiva
Market Cap: RON 3.2b
Engages in the production and marketing of preparations and medicines for human use in Romania and internationally.
SCD
RON 4.52
7D
0%
1Y
55.9%
Handa Pharmaceuticals
Market Cap: NT$18.7b
A specialty pharmaceutical company, focuses on the development of drugs for various diseases in the United States.
6620
NT$120.50
7D
-9.1%
1Y
93.7%
Niagen Bioscience
Market Cap: US$602.6m
Operates as a bioscience company engages in developing healthy aging products.
NAGE
US$7.23
7D
-4.9%
1Y
26.0%
Ever Supreme Bio Technology
Market Cap: NT$14.1b
Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells in Taiwan.
6712
NT$162.00
7D
-0.6%
1Y
-1.8%
RPG Life Sciences
Market Cap: ₹40.4b
An integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally.
RPGLIFE
₹2,462.60
7D
3.6%
1Y
-6.5%
GlaxoSmithKline Pakistan
Market Cap: PK₨127.5b
Operates as a biopharma company in Pakistan.
GLAXO
PK₨400.31
7D
0.2%
1Y
37.3%
Novartis India
Market Cap: ₹21.6b
Novartis India Limited is involved in the pharmaceutical business in India.
500672
₹858.05
7D
-0.6%
1Y
-20.2%
Savior Lifetec
Market Cap: NT$5.4b
A specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations.
4167
NT$16.70
7D
-2.1%
1Y
-22.7%
Jagsonpal Pharmaceuticals
Market Cap: ₹15.1b
Engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally.
JAGSNPHARM
₹216.61
7D
-2.7%
1Y
-9.7%
Genovis AB (publ.)
Market Cap: SEK 1.5b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 22.65
7D
-2.4%
1Y
3.4%
Quality Chemical Industries
Market Cap: USh423.1b
Manufactures and sells pharmaceutical drugs in Uganda.
QCIL
USh115.87
7D
0.8%
1Y
110.7%
Jenburkt Pharmaceuticals
Market Cap: ₹5.6b
Researches and develops, manufactures, and markets pharmaceutical and healthcare products in India.
524731
₹1,262.15
7D
18.4%
1Y
16.1%
G.F.C Green Fields Capital
Market Cap: ₪137.4m
Does not have significant operations.
GFC-M
₪13.69
7D
0.4%
1Y
19.0%
Cryosite
Market Cap: AU$58.6m
Provides outsourced clinical trials logistic services in Australia.
CTE
AU$1.19
7D
-8.5%
1Y
25.3%
Alpa Laboratories
Market Cap: ₹1.9b
Engages in the manufacture and sale of drugs and chemicals in India.
ALPA
₹89.26
7D
-0.08%
1Y
-20.0%
Par Drugs and Chemicals
Market Cap: ₹1.3b
Develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India.
PAR
₹99.15
7D
-1.6%
1Y
-67.2%
Amwill Health Care
Market Cap: ₹1.1b
A derma-cosmetic company, engages in the development and contract manufacturing of generic dermatological solutions in India.
544353
₹55.83
7D
4.1%
1Y
n/a